Cargando…

Impact of blood group on survival following critical illness: a single-centre retrospective observational study

BACKGROUND: Predicting patient outcomes following critical illness is challenging. Recent evidence has suggested that patients with blood group AB are more likely to survive following major cardiac surgery, and this is associated with a reduced number of blood transfusions. However, there are no cur...

Descripción completa

Detalles Bibliográficos
Autores principales: Slade, Robert, Alikhan, Raza, Wise, Matt P, Germain, Lam, Stanworth, Simon, Morgan, Matt
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BMJ Publishing Group 2019
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6606056/
https://www.ncbi.nlm.nih.gov/pubmed/31321058
http://dx.doi.org/10.1136/bmjresp-2019-000426
_version_ 1783431850575790080
author Slade, Robert
Alikhan, Raza
Wise, Matt P
Germain, Lam
Stanworth, Simon
Morgan, Matt
author_facet Slade, Robert
Alikhan, Raza
Wise, Matt P
Germain, Lam
Stanworth, Simon
Morgan, Matt
author_sort Slade, Robert
collection PubMed
description BACKGROUND: Predicting patient outcomes following critical illness is challenging. Recent evidence has suggested that patients with blood group AB are more likely to survive following major cardiac surgery, and this is associated with a reduced number of blood transfusions. However, there are no current data to indicate whether a patient’s blood group affects general intensive care outcomes. OBJECTIVE: The objective of this study was to determine if ABO blood group affects survival in intensive care. The primary outcome measure was 90-day mortality with a secondary outcome measure of the percentage of patients receiving a blood transfusion. DESIGN: Retrospective analysis of electronically collected intensive care data, blood group and transfusion data. SETTING: General intensive care unit (ICU) of a major tertiary hospital with both medical and surgical patients. PATIENTS: All patients admitted to ICU between 2006 and 2016 who had blood group data available. INTERVENTION: None. MEASUREMENTS AND MAIN RESULTS: 7340 patients were included in the study, blood group AB accounted for 3% (221), A 41% (3008), B 10.6% (775) and O 45.4% (3336). These values are similar to UK averages. Baseline characteristics between the groups were similar. Blood group AB had the greatest survival benefit (blood group AB 90-day survival estimate 76.75, 95% CI 72.89 to 80.61 with the overall estimate 72.07, 95% CI 71.31 to 72.82) (log-rank χ(2) 16.128, p=0.001). Transfusion requirements were similar in all groups with no significant difference between the percentages of patients transfused (AB 23.1%, A 21.5%, B 18.7%, O 19.9%, Pearson χ(2) 5.060 p=0.167). CONCLUSION: Although this is primarily a hypothesis generating study, intensive care patients with blood group AB appeared to have a higher 90-day survival compared with other blood groups. There was no correlation between blood group and percentage of patients receiving transfusion.
format Online
Article
Text
id pubmed-6606056
institution National Center for Biotechnology Information
language English
publishDate 2019
publisher BMJ Publishing Group
record_format MEDLINE/PubMed
spelling pubmed-66060562019-07-18 Impact of blood group on survival following critical illness: a single-centre retrospective observational study Slade, Robert Alikhan, Raza Wise, Matt P Germain, Lam Stanworth, Simon Morgan, Matt BMJ Open Respir Res Critical Care BACKGROUND: Predicting patient outcomes following critical illness is challenging. Recent evidence has suggested that patients with blood group AB are more likely to survive following major cardiac surgery, and this is associated with a reduced number of blood transfusions. However, there are no current data to indicate whether a patient’s blood group affects general intensive care outcomes. OBJECTIVE: The objective of this study was to determine if ABO blood group affects survival in intensive care. The primary outcome measure was 90-day mortality with a secondary outcome measure of the percentage of patients receiving a blood transfusion. DESIGN: Retrospective analysis of electronically collected intensive care data, blood group and transfusion data. SETTING: General intensive care unit (ICU) of a major tertiary hospital with both medical and surgical patients. PATIENTS: All patients admitted to ICU between 2006 and 2016 who had blood group data available. INTERVENTION: None. MEASUREMENTS AND MAIN RESULTS: 7340 patients were included in the study, blood group AB accounted for 3% (221), A 41% (3008), B 10.6% (775) and O 45.4% (3336). These values are similar to UK averages. Baseline characteristics between the groups were similar. Blood group AB had the greatest survival benefit (blood group AB 90-day survival estimate 76.75, 95% CI 72.89 to 80.61 with the overall estimate 72.07, 95% CI 71.31 to 72.82) (log-rank χ(2) 16.128, p=0.001). Transfusion requirements were similar in all groups with no significant difference between the percentages of patients transfused (AB 23.1%, A 21.5%, B 18.7%, O 19.9%, Pearson χ(2) 5.060 p=0.167). CONCLUSION: Although this is primarily a hypothesis generating study, intensive care patients with blood group AB appeared to have a higher 90-day survival compared with other blood groups. There was no correlation between blood group and percentage of patients receiving transfusion. BMJ Publishing Group 2019-06-29 /pmc/articles/PMC6606056/ /pubmed/31321058 http://dx.doi.org/10.1136/bmjresp-2019-000426 Text en © Author(s) (or their employer(s)) 2019. Re-use permitted under CC BY-NC. No commercial re-use. See rights and permissions. Published by BMJ. This is an open access article distributed in accordance with the Creative Commons Attribution Non Commercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited, appropriate credit is given, any changes made indicated, and the use is non-commercial. See: http://creativecommons.org/licenses/by-nc/4.0/.
spellingShingle Critical Care
Slade, Robert
Alikhan, Raza
Wise, Matt P
Germain, Lam
Stanworth, Simon
Morgan, Matt
Impact of blood group on survival following critical illness: a single-centre retrospective observational study
title Impact of blood group on survival following critical illness: a single-centre retrospective observational study
title_full Impact of blood group on survival following critical illness: a single-centre retrospective observational study
title_fullStr Impact of blood group on survival following critical illness: a single-centre retrospective observational study
title_full_unstemmed Impact of blood group on survival following critical illness: a single-centre retrospective observational study
title_short Impact of blood group on survival following critical illness: a single-centre retrospective observational study
title_sort impact of blood group on survival following critical illness: a single-centre retrospective observational study
topic Critical Care
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6606056/
https://www.ncbi.nlm.nih.gov/pubmed/31321058
http://dx.doi.org/10.1136/bmjresp-2019-000426
work_keys_str_mv AT sladerobert impactofbloodgrouponsurvivalfollowingcriticalillnessasinglecentreretrospectiveobservationalstudy
AT alikhanraza impactofbloodgrouponsurvivalfollowingcriticalillnessasinglecentreretrospectiveobservationalstudy
AT wisemattp impactofbloodgrouponsurvivalfollowingcriticalillnessasinglecentreretrospectiveobservationalstudy
AT germainlam impactofbloodgrouponsurvivalfollowingcriticalillnessasinglecentreretrospectiveobservationalstudy
AT stanworthsimon impactofbloodgrouponsurvivalfollowingcriticalillnessasinglecentreretrospectiveobservationalstudy
AT morganmatt impactofbloodgrouponsurvivalfollowingcriticalillnessasinglecentreretrospectiveobservationalstudy